Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial Patients
Medicare officials said they would cover Biogen Inc.’s BIIB 2.64% controversial Alzheimer’s disease drug Aduhelm on the condition that patients...
Medicare officials said they would cover Biogen Inc.’s BIIB 2.64% controversial Alzheimer’s disease drug Aduhelm on the condition that patients...
A California judge said the November ballot measure that allowed Uber Technologies Inc., Lyft Inc. and DoorDash Inc. to continue...
The Biden administration took steps Wednesday to crack down on rising Covid-19 cases, including a call for a third shot...
A collection agent for Medicare service providers is suing one of the dozens of trusts established by bankrupt asbestos manufacturers...
The White House call for revised enforcement guidelines to promote hospital competition will likely amplify federal scrutiny of hospital mergers,...